Skip to main content

Advertisement

Table 2 Results of blood examination results from the retro-orbital sinus of mice after the administration of liposome formulations

From: Preparation and Evaluation of Liposomes Co-Loaded with Doxorubicin, Phospholipase D Inhibitor 5-Fluoro-2-Indolyl Deschlorohalopemide (FIPI) and D-Alpha Tocopheryl Acid Succinate (α-TOS) for Anti-Metastasis

Assay Control Blank-lip DFT-lip
GR 1.25 ± 0.44 1.27 ± 0.51 1.09 ± 0.64
GR% 17.20 ± 5.44 17.29 ± 5.97 18.85 ± 12.29
HCT 49.04 ± 1.01 48.96 ± 2.24 48.41 ± 1.68
HGB 163.25 ± 4.27 160.00 ± 4.87 156.25 ± 5.34
LY 5.11 ± 0.96 4.43 ± 0.97 4.04 ± 1.07
LY% 69.81 ± 7.25 63.34 ± 8.49 63.99 ± 10.53
MCH 16.28 ± 0.38 16.28 ± 0.34 15.84 ± 0.35
MCHC 333.00 ± 9.21 327.13 ± 8.85 322.63 ± 6.21
MCV 48.85 ± 1.11 49.76 ± 1.26 49.10 ± 1.22
MO 0.94 ± 0.40 1.34 ± 0.43 1.09 ± 0.34
MO% 12.99 ± 5.56 19.37 ± 5.54 17.16 ± 3.74
MPV 5.31 ± 0.15 5.45 ± 0.21 5.51 ± 0.17
PCT 0.24 ± 0.03 0.26 ± 0.02 0.23 ± 0.03
PDW 13.61 ± 0.79 13.94 ± 0.96 13.74 ± 0.39
PLT 451.25 ± 47.78 481.75 ± 32.47 419.38 ± 44.64
RBC 10.04 ± 0.26 9.83 ± 0.42 9.85 ± 0.21
RDW 14.25 ± 0.97 14.19 ± 0.66 14.73 ± 1.07
WBC 7.30 ± 1.22 7.04 ± 1.29 6.21 ± 0.96
  1. Data are presented as the mean ± SD (n = 8). GR, neutrophil granulocyte; HCT, hematocrit; HGB, hemoglobin; LY, lymphocyte; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; MO, intermediate cell; MPV, mean platelet volume; PCT, thrombocytocrit; PDW, platelet distribution width; PLT, platelet; RBC, red blood cells; RDW, red cell volume distribution width; WBC, white blood cells